Trial Profile
A 13 month, randomised, double-blind, parallel-group comparison of the efficacy of seretide (fluticasone propionate/salmeterol combination Accuhaler) and Flixotide (fluticasone propionate Accuhaler) when down-titrating the inhaled corticosteroid dose in asthmatic adults who have previously received Seretide 500/50 microg twice daily for at least 4 weeks.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2023
Price :
$35
*
At a glance
- Drugs Fluticasone propionate (Primary) ; Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 06 Nov 2006 New trial record.